Rating: 
Summary: Well written, fast paced, yet thorough
Review: The author's expertise in science, finance, management strategy, and journalism all pay off in this very well written book. It's both lively and fact-packed, with quite a few tables covering dozens or hundreds of IPOs in the biotech industry. It gives a spectrum of biotech probably much broader than what any one reader would be familiar with. In a few places, I would have liked a bit more detail: for example, in the IPO chapter, a paragraph about exactly what the investment bank "does", how it "does" it, what its risks are in taking on an IPO, etc.
Rating:
Summary: Superb!
Review: The book gives a good background for people interested in life sciences, life sciences investment and the clinical trial process. For the layperson, knowing what happens in the drug evaluation process is interesting. Chapter Six alone, on biotechnology and NASA is an eye opening -- it is interesting, scary and evokes ethical considerations
Rating:
Summary: Top of the line
Review: This book is worth every dime and much more. Presents the latest twists and turns in biotech, including the early bonanza. Although every word is worth its place this is not heavy and booring at any time. Biotech is a field hard for 'outsiders' to grasp. After reading this book even a novice will feel at home and for the more wised it is just informative and above all also entertaining - qualities rarely found inside the same cover.
Rating: 
Summary: Brilliant Overview
Review: This is a great overview of the world of biotech. The author explains the science with clarity and enthusiasm and the introduction this book provides to the corporate side of biotech is also very interesting and well written.
Rating:
Summary: Brilliant Overview
Review: This is a great overview of the world of biotech. The author explains the science with clarity and enthusiasm and the introduction this book provides to the corporate side of biotech is also very interesting and well written.
Rating:
Summary: From Alchemy to IPO --the REAL biotech story revealed!
Review: This is flat out the best book I've read on the biotechnology industry. I found it a riveting journey through both the science and the business of biotechnology, as well as a fascinating introduction to some of the outsize personalities who have invented the industry. The author, Cynthia Robbins-Roth, has a knack for translating complicated science and business issues into language that is both entertaining and, most importantly, understandable (thank you!). This book would make a great movie!
Rating: 
Summary: WAY OVERRATED BOOK ON BIOTECH
Review: to quote another user: "The author's expertise in science, finance, management strategy, and journalism..." the author can write decently and she may know about biotech (hard to judge for me not being a scientist)...BUT her knowledge about management strategy and finance is limited at best...that wouldn't be so bad if she were to stick to write about science...however, she thinks she knows about finance and strategy...who wants to read about strategy should stick with hamel, pralahad, porter etc., who wants to read about finance (valuation) should stick with copeland et al, and who wants to read about ipos should try articles by jay ritter.
Rating:
Summary: WAY OVERRATED BOOK ON BIOTECH
Review: to quote another user: "The author's expertise in science, finance, management strategy, and journalism..." the author can write decently and she may know about biotech (hard to judge for me not being a scientist)...BUT her knowledge about management strategy and finance is limited at best...that wouldn't be so bad if she were to stick to write about science...however, she thinks she knows about finance and strategy...who wants to read about strategy should stick with hamel, pralahad, porter etc., who wants to read about finance (valuation) should stick with copeland et al, and who wants to read about ipos should try articles by jay ritter.
|
